Five things for pharma marketers to know: Tuesday, December 5, 2017

Five things for pharma marketers to know: Tuesday, December 5, 2017

Botox-like wrinkle-reducer shows positive results in trials; investors double down on fertility; few websites transparent about pricing, study finds

GroupM unveils upbeat global adspend forecast for 2018

GroupM unveils upbeat global adspend forecast for 2018

GroupM, the media investment arm of WPP, forecasts global ad growth of 4.3% in 2018, and predicts Google and Facebook will strengthen their stranglehold on digital advertising.

'Coco' filmmakers discover family history in latest Ancestry spot

'Coco' filmmakers discover family history in latest Ancestry spot

Content Collective takes the Pixar film's creators on their own genealogy journeys.

Five things for pharma marketers to know: Monday, December 4, 2017

Five things for pharma marketers to know: Monday, December 4, 2017

CVS to buy Aetna for $69 billion; J&J buys commercial rights for biotech's experimental hypertension drug; Republicans repeal Obamacare's individual mandate

Publicis.Sapient's Alan Wexler steps up as digital chief Chip Register retires

Publicis.Sapient's Alan Wexler steps up as digital chief Chip Register retires

Publicis Groupe has named Alan Wexler as chief executive of Publicis.Sapient as Chip Register has chosen to retire at the end of the year.

Five things for pharma marketers to know: Thursday, November 30, 2017

Five things for pharma marketers to know: Thursday, November 30, 2017

FDA releases information on Exondys 51; Sanofi's dengue vaccine faces new restrictions; Kellyanne Conway named opioid czar

HHS nominee Alex Azar: Medicare Part B should negotiate drug prices

HHS nominee Alex Azar: Medicare Part B should negotiate drug prices

Alex Azar, previously a senior executive at Eli Lilly, proposed granting Part B the authority to negotiate lower prices.

Five things for pharma marketers to know: Wednesday, November 29, 2017

Five things for pharma marketers to know: Wednesday, November 29, 2017

U.K. to be first to sell OTC Viagra; Regeneron offers startup scientific expertise; docs more likely to get poor marks when they reject patient requests

Amazon sets its sights on healthcare

Amazon sets its sights on healthcare

How worried should the industry's other major players be?

Pfizer campaign aims to keep boomers healthy

Pfizer campaign aims to keep boomers healthy

Company enlists Patti LaBelle to increase awareness for the pneumococcal pneumonia vaccine

Five things for pharma marketers to know: Tuesday, November 28, 2017

Five things for pharma marketers to know: Tuesday, November 28, 2017

FDA plans new guidance to bring complex generics to market more quickly; BioMarin sells priority review voucher for $125 million; Takeda expects Zika clinical trial results next year

OPDP issues third enforcement letter of 2017

OPDP issues third enforcement letter of 2017

The FDA's Office of Prescription Drug Promotion issued a warning letter to Amherst Pharmaceuticals and Magna Pharmaceutical.

Facebook explains advertising policies to its users but industry wants more

Facebook explains advertising policies to its users but industry wants more

Facebook has formally outlined is advertising policies to its users but the industry feels the internet giant is offloading responsibility instead of stepping up.

Five things for pharma marketers to know: Monday, November 27, 2017

Five things for pharma marketers to know: Monday, November 27, 2017

Teva to cut thousands of U.S. jobs; Regeneron drops Eylea combo drug development; insurers, drugstores, and hospitals increasingly teaming up

How working with Apple inspired Jeff Tangney to found Doximity

How working with Apple inspired Jeff Tangney to found Doximity

The CEO's experience launching medical reference app Epocrates led him to found a social network for physicians.

Five things for pharma marketers to know: Wednesday, November 22, 2017

Five things for pharma marketers to know: Wednesday, November 22, 2017

WebMD reportedly lays off 10% of workforce; Roche blocks Herceptin biosimilar with patent suit; insurers cover Collegium's Xtampza over Purdue's OxyContin

Five things for pharma marketers to know: Tuesday, November 21, 2017

Five things for pharma marketers to know: Tuesday, November 21, 2017

J&J to hold meeting on maintaining Remicade market share; Acorda ends development of Parkinson's drug; Darzalex notches positive first-line results

PRWeek and MM&M hire NBC exec for custom content role

PRWeek and MM&M hire NBC exec for custom content role

Emmy-nominated Maia Samuel becomes executive director of expanded Haymarket Content Lab; Bernadette Casey promoted to executive director of Haymarket Content Hub.

What does Twitter's 280 characters mean for pharma?

What does Twitter's 280 characters mean for pharma?

Marketers survey the pluses and minuses of the platform's new 280-character limit.

Five things for pharma marketers to know: Monday, November 20, 2017

Five things for pharma marketers to know: Monday, November 20, 2017

The FDA approves EpiPen competitor Auvi-Q for small children; pharma executives are warm up to Amazon; Purdue approached states about opioid-epidemic settlement

Five things for pharma marketers to know: Friday, November 17, 2017

Five things for pharma marketers to know: Friday, November 17, 2017

FDA approves Genentech's hemophilia drug; former Insys CEO pleads not guilty to bribery charges; federal jury rules in favor of Endo in Testim lawsuit

Five things for pharma marketers to know: Thursday, November 16, 2017

Five things for pharma marketers to know: Thursday, November 16, 2017

Docs biased against research from poor countries, study finds; Astellas probed over patient-assistance charity support; Acorda reports deaths in Parkinson's trial

Lions Health to remain segregated after Cannes revamp

Lions Health to remain segregated after Cannes revamp

Lions Health still stands as a separate two-day event, despite a sweeping revamp of the Cannes Lions festival, disappointing some who decried its lack of full integration within the larger program.

Cut-down Cannes 'saluted' by Publicis despite pull-out, as others give more cautious welcome

Cut-down Cannes 'saluted' by Publicis despite pull-out, as others give more cautious welcome

French holding company Publicis has welcomed the raft of changes announced to the Cannes Lions festival Monday, while others have given it a more cautious welcome.

Five things for pharma marketers to know: Wednesday, November 15, 2017

Five things for pharma marketers to know: Wednesday, November 15, 2017

FDA approves AstraZeneca asthma drug; Senate tax reform bill would repeal Obamacare mandate; J&J drops Remicade biosimilar lawsuit

Centers for Medicare and Medicaid Services puts $900m IDIQ up for bid

Centers for Medicare and Medicaid Services puts $900m IDIQ up for bid

Ketchum, Ogilvy, Porter Novelli, Weber Shandwick, and FleishmanHillard are among the firms that have been awarded past Centers for Medicare and Medicaid Services IDIQ accounts.

Drugmakers and celebrities partner to raise diabetes awareness

Drugmakers and celebrities partner to raise diabetes awareness

Celebrities such as Angela Bassett and Mike Golic share their personal experiences about diabetes.

Five things for pharma marketers to know: Tuesday, November 14, 2017

Five things for pharma marketers to know: Tuesday, November 14, 2017

FDA approves first digital pill; biotech companies race to develop cancer-fighting microbiome drugs; Loxo and Bayer reach $1.55 billion deal for rare cancer drugs

Five things for pharma marketers to know: Monday, November 13, 2017

Five things for pharma marketers to know: Monday, November 13, 2017

Dynavax receives FDA approval for hepatitis-B vaccine; Novartis strikes R&D deal with gene-editing startup; White House nominates new HHS head

Edelman health veteran Donna Duncan joins W2O Chicago

Edelman health veteran Donna Duncan joins W2O Chicago

W2O's Windy City office has added three health and analytics leaders over the past six months.

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Former HealthCare.gov comms staffers fill in for the government with ACA campaign

Get America Covered is working to encourage consumers to sign up for coverage through the Affordable Care Act.

Five things for pharma marketers to know: Friday, November 10, 2017

Five things for pharma marketers to know: Friday, November 10, 2017

AstraZeneca sales fall on generic competition; Anthem broadens access for Duchenne muscular dystrophy drug; researchers are developing new biopsy techniques

Five things for pharma marketers to know: Thursday, November 9, 2017

Five things for pharma marketers to know: Thursday, November 9, 2017

GSK hires Google biotech exec to lead R&D; Merck gets FDA-approval for CMV therapy; ex-Lilly exec reportedly top HHS secretary pick

Omnicom promotes Biolumina and H&S presidents to CEO

Omnicom promotes Biolumina and H&S presidents to CEO

Ty Curran, previously CEO of the sister agencies, will serve as chairman in 2018.

Armed with predictive analytics, PBMs push adherence as a stand-in for outcomes

Armed with predictive analytics, PBMs push adherence as a stand-in for outcomes

Pharmacy benefit managers are increasingly measuring a patient's outcome in the context of adherence.

Five things for pharma marketers to know: Wednesday, November 8, 2017

Five things for pharma marketers to know: Wednesday, November 8, 2017

FDA to change Risk Evaluation Mitigation Strategies to prevent delayed generic approvals; Ohio rejects drug-price measure; Aetna CEO wants to improve in-person pharmacy experience

Limits on pharma payments to doctors back on policy menu

Limits on pharma payments to doctors back on policy menu

A mini wave of state-level rule-making has thrust the issue of restrictions on pharma payments to medical professionals back into the spotlight.

Five things for pharma marketers to know: Tuesday, November 7, 2017

Five things for pharma marketers to know: Tuesday, November 7, 2017

Senator investigates Alkermes' opioid-marketing tactics; FDA approves Roche cancer drugs; CVS to launch next-day delivery nationwide

CDC tells opioid addiction stories with message: 'It only takes a little to lose a lot'

CDC tells opioid addiction stories with message: 'It only takes a little to lose a lot'

The CDC has launched the first wave of its awareness campaign about prescription opioids.

Maurice Lévy on his 30 years in charge of Publicis Groupe

Maurice Lévy on his 30 years in charge of Publicis Groupe

Midway through Campaign's audience with Publicis Groupe's Maurice Lévy, a heavily French-accented voice exclaims, "Now it is time for the real boss to arrive."

Five things for pharma marketers to know: Monday, November 6, 2017

Five things for pharma marketers to know: Monday, November 6, 2017

Valeant sells Addyi back to Sprout; some advertisers halt business with Outcome Health; Amgen cuts R&D jobs

P&G slashed the number of sites it ran ads on by nearly 70% after YouTube brand safety scandal

P&G slashed the number of sites it ran ads on by nearly 70% after YouTube brand safety scandal

In April, a month or so after brands were accused of funding terrorist videos on YouTube, Procter & Gamble cut down the number of sites its ads ran on by 69%.

Barby Ingle on the challenges of healthcare influencer marketing

Barby Ingle on the challenges of healthcare influencer marketing

The blogger talks the challenges of influencer marketing in healthcare, chronic disease, and big brand activations.

Five things for pharma marketers to know: Friday, November 3, 2017

Five things for pharma marketers to know: Friday, November 3, 2017

Experimental Gilead and GSK HIV drugs are expected to compete; GSK R&D head resigns; Valeant subsidiary scores eye-drug approval

Five things for pharma marketers to know: Thursday, November 2, 2017

Five things for pharma marketers to know: Thursday, November 2, 2017

Teva reports lower-than-expected Q3 earnings; BI and Dicerna partner in NASH drug development; AstraZeneca's experimental asthma drug fails in Phase-III

Pfizer bolsters Eucrisa launch with two DTC campaigns

Pfizer bolsters Eucrisa launch with two DTC campaigns

Forecasts anticipate sales of $1.3 billion in five years.

Front seat to the comms evolution: Abbott's Melissa Brotz

Front seat to the comms evolution: Abbott's Melissa Brotz

The divisional VP and head of public affairs has seen it all, including the transformation from a traditional comms organization to a more dynamic and content-led group.

Analysts agree with WPP that threat from consultancies has been 'overhyped'

Analysts agree with WPP that threat from consultancies has been 'overhyped'

During its third quarter earnings call yesterday, WPP dismissed the threat from management consultants as "overhyped". Analysts concur.

Five things for pharma marketers to know: Wednesday, November 1, 2017

Five things for pharma marketers to know: Wednesday, November 1, 2017

Drug industry spends nearly $50 million to fight drug-price referendum; Novartis weighs sales of generic unit; ICER to evaluate all newly approved drugs

MM&M and PRWeek unveil the 2017 Health Influencer 50

MM&M and PRWeek unveil the 2017 Health Influencer 50

MM&M and PRWeek have revealed the 2017 Health Influencer 50, a list honoring professionals across the health spectrum for their passion, determination, and innovative thinking that has helped guide the industry through two turbulent and exciting decades.

Five things for pharma marketers to know: Tuesday, October 31, 2017

Five things for pharma marketers to know: Tuesday, October 31, 2017

Pfizer Q3 revenue driven by Prevnar sales; President Trump's opioid panel presents draft to combat crisis; Novartis seeks FDA approval for CAR-T therapy Kymriah

Five things for pharma marketers to know: Monday, October 30, 2017

Five things for pharma marketers to know: Monday, October 30, 2017

Novartis to acquire French biotech in bid to develop new cancer therapies; FDA hires former Mylan exec as comms adviser; health system sees drop in opioid scripts

Doctors who receive gifts from industry prescribe more branded drugs: study

Doctors who receive gifts from industry prescribe more branded drugs: study

In 2013, Medicare Part D prescribers who received a gift from a drugmaker prescribed 8% more brand-name drugs.

GCI Health, HealthyWomen, Redbook partner to learn about women's health

GCI Health, HealthyWomen, Redbook partner to learn about women's health

The HealthiHER project has commissioned a survey of women aged 30 to 60 to inform future campaigns.

Porter Novelli wins lucrative multi-year CSR brief with Johnson & Johnson

Porter Novelli wins lucrative multi-year CSR brief with Johnson & Johnson

Porter Novelli has been appointed to lead a new global CSR brief for pharma and consumer goods giant Johnson & Johnson, as the company faces a major reputation challenge in the US.

Five things for pharma marketers to know: Friday, October 27, 2017

Five things for pharma marketers to know: Friday, October 27, 2017

CVS Health reportedly in talks to acquire Aetna; Amazon acquires wholesale pharmacy licenses; Merck says June cyberattack disrupted global operations

StoneArch hires Marcia Miller as new president

StoneArch hires Marcia Miller as new president

Optum vet Miller replaces Jessica Boden.

Five things for pharma marketers to know: Thursday, October 26, 2017

Five things for pharma marketers to know: Thursday, October 26, 2017

Non-profit challenges Gilead's Sovaldi patent; The Medicines Company to cut hundreds of jobs; Amgen ends R&D for experimental CETP drug

Why haven't biosimilars gained ground in the U.S.?

Why haven't biosimilars gained ground in the U.S.?

Two years after the first biosimilar approval in the U.S., biosimilars have yet to match sales forecasts. What is their path forward?

Five things for pharma marketers to know: Wednesday, October 25, 2017

Five things for pharma marketers to know: Wednesday, October 25, 2017

FDA develops resources about biosimilars for HCPs; Biogen negotiates royalties for experimental Alzheimer's drug; GSK Q3 sales driven by HIV, respiratory drugs

W2O looks to eliminate confusion with network rebrand

W2O looks to eliminate confusion with network rebrand

The agency network is rebranding five subsidiaries under the W2O banner.

10 questions for PhRMA's CEO Stephen Ubl

10 questions for PhRMA's CEO Stephen Ubl

Trade group PhRMA's CEO talks about his first year in the job amid public outrage about price gouging.

Five things for pharma marketers to know: Tuesday, October 24, 2017

Five things for pharma marketers to know: Tuesday, October 24, 2017

FDA approves Alexion's Soliris for another rare disease; Sun Pharma debuts companion mobile app for acne drug; Hurricane halts manufacturing in Puerto Rico

Sanofi asks the world 'How are you?' in latest corporate branding campaign

Sanofi asks the world 'How are you?' in latest corporate branding campaign

The Paris-based pharma company debuted a brand campaign and signature last week.

Five things for pharma marketers to know: Monday, October 23, 2017

Five things for pharma marketers to know: Monday, October 23, 2017

Biosimilars could save $54 billion in next decade; White House requests drug-pricing task force; FDA approves GSK shingle vaccine

Merck to axe 1,800 sales positions, form new chronic-care sales team

Merck to axe 1,800 sales positions, form new chronic-care sales team

The drugmaker eliminated its U.S. primary care, disease-focused endocrinology, and hospital chronic-care sales teams.

My career in 5 executions: Saatchi & Saatchi Wellness' Kathy Delaney

My career in 5 executions: Saatchi & Saatchi Wellness' Kathy Delaney

From IKEA to eye-opening health campaigns, S&S Wellness' CCO helps turn emotion into action.

Phoenix House tries to change the perception of rehab

Phoenix House tries to change the perception of rehab

The organization rolled out a video this week as part of its Live Unaddicted campaign to change the perception of addiction treatment.

Five things for pharma marketers to know: Friday, October 20, 2017

Five things for pharma marketers to know: Friday, October 20, 2017

Merck lays off 1,800 employees, launches new sales force; Celgene ends development of Crohn's disease drug; PBMs come under increased scrutiny

Area 23, 2e Creative, and Digitas Health win big at 2017 MM&M Awards

Area 23, 2e Creative, and Digitas Health win big at 2017 MM&M Awards

Area 23 netted three gold awards, and 2e Creative won Small Agency of the Year for the third year in a row.

Up to 20% of pharma brands moving digital media spend to point-of-care

Up to 20% of pharma brands moving digital media spend to point-of-care

Two point-of-care companies have received hundreds of millions of dollars in funding. One of them, Outcome Health, is facing allegations about padding data.

Five things for pharma marketers to know: Thursday, October 19, 2017

Five things for pharma marketers to know: Thursday, October 19, 2017

The FDA approves Kite's CAR-T therapy; Omnicom reports strong Q3 performance for healthcare agencies; Hearst to acquire Rodale, up health presence

Five things for pharma marketers to know: Wednesday, October 18, 2017

Five things for pharma marketers to know: Wednesday, October 18, 2017

More than half of doctors say patients make critical, racist, or sexist comments; Anthem to launch its own PBM; drugmakers face criticism for waste

Novo's experimental diabetes drug likely to compete with Trulicity

Novo's experimental diabetes drug likely to compete with Trulicity

An FDA advisory committee is scheduled to vote Wednesday on whether to approve Novo's semaglutide, which, if approved, could steal market share from Eli Lilly's Trulicity.

Wellpepper wins Alexa Diabetes Challenge

Wellpepper wins Alexa Diabetes Challenge

The health startup's system has a foot scanner that can take photos of a patient's feet and can look for potential foot ulcers using a machine learning image classifier.

Five things for pharma marketers to know: Tuesday, October 17, 2017

Five things for pharma marketers to know: Tuesday, October 17, 2017

J&J reports 15% lift in pharma sales in Q3; Apple reportedly considers buying medical clinics; survey finds need for digital investment in payer marketing

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Drugmakers begin to up media controls, in bid to clean up digital ad supply

Like its consumer-products cousins, pharma marketers are exercising more discipline over online media. Will it yield similar results?

Five things for pharma marketers to know: Monday, October 16, 2017

Five things for pharma marketers to know: Monday, October 16, 2017

FDA briefing document affirms diabetes drug's efficacy; J&J debuts new tools to improve adherence; AZ says cancer drug data was falsified

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

IntrusiveThoughts.org takes 'approachable' approach to redesign of OCD site

Two key creators from Ready Set Rocket share how a thoughtful execution can destigmatize mental illness.

Five things for pharma marketers to know: Friday, October 13, 2017

Five things for pharma marketers to know: Friday, October 13, 2017

Outcome Health reportedly misled advertisers; FDA committee recommends gene therapy; Avanir drug is highly prescribed by docs paid by company

Muscular Dystrophy Association taps Lynn O'Connor Vos as CEO

Muscular Dystrophy Association taps Lynn O'Connor Vos as CEO

The association said it is preparing for new FDA approvals for therapies that treat central nervous system and muscular system diseases.

Five things for pharma marketers to know: Thursday, October 12, 2017

Five things for pharma marketers to know: Thursday, October 12, 2017

Merck scraps plans for cholesterol drug; oncologist describes how he tells people about his work; researchers question list of side effects in DTC ads

Nonprofits focus attention on metastatic breast cancer this October

Nonprofits focus attention on metastatic breast cancer this October

Susan G. Komen and the Breast Cancer Research Foundation are focusing on raising awareness and research money for the deadliest forms of the disease.

Five things for pharma marketers to know: Wednesday, October 11, 2017

Five things for pharma marketers to know: Wednesday, October 11, 2017

Pfizer considers sale of its consumer healthcare business; Express Scripts moves into patient benefit management; China to speed up drug approvals

Five things for pharma marketers to know: Tuesday, October 10, 2017

Five things for pharma marketers to know: Tuesday, October 10, 2017

Patients complain about positive healthcare ads; some drugmakers skirt Open Payment rules; new law requires disclosure of drug price hikes in California

Astellas turns to 'corporate branding 2.0'

Astellas turns to 'corporate branding 2.0'

The communications team, led by Jeff Winton, is again researching Astellas' reputation for an updated picture on where the campaign has gotten them so far.

Five things for pharma marketers to know: Friday, October 6, 2017

Five things for pharma marketers to know: Friday, October 6, 2017

AbbVie to pay $140 million to AndroGel patient; Trump likely to roll back birth-control mandate; patients more likely to respond to expensive drugs

Five things for pharma marketers to know: Thursday, October 5, 2017

Five things for pharma marketers to know: Thursday, October 5, 2017

Cigna will no longer cover OxyContin; the AMA no longer supports price-fixing to lower drug prices; Gottlieb is not in favor of 'right-to-try' laws

How Walgreens overcomes 'consumer complacency' during flu-shot season

How Walgreens overcomes 'consumer complacency' during flu-shot season

In the 2015-16 flu season, more than 145 million doses were distributed by manufacturers, according to the Centers for Disease Control and Prevention, but only 41% of American adults received a vaccine.

Five things for pharma marketers to know: Wednesday, October 4, 2017

Five things for pharma marketers to know: Wednesday, October 4, 2017

The FDA approves Mylan's Copaxone generic; 3 out of every 1,000 Americans face $50,000 in drug costs; some ACA premiums may rise by 50%

How a cancer nonprofit is using Comic Con in bid for new donors

How a cancer nonprofit is using Comic Con in bid for new donors

DKMS worked with Marino on PR for the campaign and with Area 23 on its Comic Con booth.

Five things for pharma marketers to know: Tuesday, October 3, 2017

Five things for pharma marketers to know: Tuesday, October 3, 2017

The FDA wants to improve the generic drug approval process; Allergan CEO responds to criticism of patent deal; breast cancer death rate dropped 40%

How HUBs will evolve in the ever-changing healthcare landscape

How HUBs will evolve in the ever-changing healthcare landscape

The need to simplify access to treatment while finding new ways to keep patients engaged in their health and adherent is an undeniably growing trend.

Five things for pharma marketers to know: Monday, October 2, 2017

Five things for pharma marketers to know: Monday, October 2, 2017

The FDA tells 75 opioid drugmakers to fund training efforts; epilepsy drug reduces seizure frequency; FDA approves Novo's fast-acting mealtime insulin

Five things for pharma marketers to know: Friday, September 29, 2017

Five things for pharma marketers to know: Friday, September 29, 2017

Merck to stop developing hep.-C drugs; FDA approves new Lilly breast-cancer drug; California bill would outlaw co-pay cards

Five things for pharma marketers to know: Thursday, September 28, 2017

Five things for pharma marketers to know: Thursday, September 28, 2017

Universities stock vending machines with women's health products; AbbVie pays to delay Amgen's Humira biosimilar; more states likely to introduce off-label bills

WPP pulls out of Eurobest, threatens to leave Cannes

WPP pulls out of Eurobest, threatens to leave Cannes

A leaked email chain shows that WPP intends to withdraw from Ascential's Eurobest awards in London and is in discussions with the organizer about Cannes Lions.

Bank: Publicis and WPP are takeover targets, and Accenture is a 'credible buyer'

Bank: Publicis and WPP are takeover targets, and Accenture is a 'credible buyer'

Accenture or CapGemini are more likely to acquire the global agency networks than a Google or Oracle, according to a leading French bank.

Five things for pharma marketers to know: Wednesday, September 27, 2017

Five things for pharma marketers to know: Wednesday, September 27, 2017

AbbVie adds context to CEO's comments on drug pricing; Pandora makes a play for pharma ad dollars; shortages expected of drugs manufactured in Puerto Rico